Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joe Stephenson, MD
Cancer Centres of the Carolinas, Greenville, SC 29605
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rocky Mountain Cancer Centre
Denver, Colorado, United States
- Cancer Centres of Florida
Ocoee, Florida, United States
- Central Indiana Cancer Centres
Indianapolis, Indiana, United States
- Comprehensive Cancer Centres of Nevada
Las Vegas, Nevada, United States
- New York Oncology Hematology Pc
Albany, New York, United States
- Dayton Oncology and Hematology, Pa
Kettering, Ohio, United States
- Cancer Centres of the Carolinas
Greenville, South Carolina, United States
- Texas Oncology, Pa
Dallas, Texas, United States
- Tyler Cancer Centre
Tyler, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
- Northwest Cancer Specialists - Vancouver Cancer Centre
Vancouver, Washington, United States
- North Star Lodge Cancer Centre
Yakima, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 31 Aug 2011
- Completion
- 30 Sept 2011
- Last update posted
- 21 Jul 2016
- Registered enrollment
- 172
- Registry id
- NCT00705874
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.